Immunological recovery in tuberculosis/HIV co-infected patients on antiretroviral therapy: implication for tuberculosis preventive therapy.
Basel KaroGérard KrauseStefanie CastellChristian KollanOsamah HamoudaWalter Haasnull nullPublished in: BMC infectious diseases (2017)
All HIV-infected patients responded to cART. However, patients developing TB showed reduced recovery in CD4+ cell count and this might partly explain the incident TB in HIV-infected patients receiving cART. These findings reinforce the importance of adjunctive TB preventive therapy for patients with reduced recovery in CD4+ cell count.
Keyphrases
- antiretroviral therapy
- hiv infected
- hiv infected patients
- hiv aids
- mycobacterium tuberculosis
- hiv positive
- human immunodeficiency virus
- end stage renal disease
- cell therapy
- single cell
- pulmonary tuberculosis
- ejection fraction
- chronic kidney disease
- prognostic factors
- newly diagnosed
- peripheral blood
- type diabetes
- emergency department
- peritoneal dialysis
- stem cells
- adverse drug